{
  "question_id": "XREF-008",
  "question": "How did the NeuroSync acquisition impact the NIM revenue trajectory?",
  "question_type": "cross-reference",
  "config": {
    "structure": "very-deep",
    "model": "haiku",
    "loading_method": "classic",
    "load_percent": 100
  },
  "response": "{\"type\":\"result\",\"subtype\":\"success\",\"is_error\":false,\"duration_ms\":33072,\"duration_api_ms\":32971,\"num_turns\":3,\"result\":\"I apologize for the error. I'll directly provide the JSON response:\\n\\n{\\\"answer\\\": \\\"The NeuroSync acquisition dramatically transformed Soong-Daystrom's Neural Interface Modules (NIM) revenue trajectory. From an initial $890M in 2019, NIM revenue grew to $1.8B in 2021, $4.2B in 2022, $5.8B in 2023, and is estimated at $7.2B in 2024, representing sustained triple-digit percentage growth in the first two years post-acquisition. The acquisition enabled Soong-Daystrom to capture 67% market share in neural interfaces and diversify the NIM product portfolio across medical, research, and educational markets.\\\", \\\"confidence\\\": \\\"high\\\", \\\"sources_used\\\": [\\\"@soong-daystrom/company/structure/leadership/executive-team/\\\", \\\"@soong-daystrom/company/business/offerings/product-lines/\\\", \\\"@soong-daystrom/company/finance/accounting/reports/\\\"]}\",\"session_id\":\"ffb91fae-9af0-49cc-951c-fd11440bf32d\",\"total_cost_usd\":0.04656136,\"usage\":{\"input_tokens\":12,\"cache_creation_input_tokens\":4407,\"cache_read_input_tokens\":63927,\"output_tokens\":712,\"server_tool_use\":{\"web_search_requests\":0,\"web_fetch_requests\":0},\"service_tier\":\"standard\",\"cache_creation\":{\"ephemeral_1h_input_tokens\":4407,\"ephemeral_5m_input_tokens\":0}},\"modelUsage\":{\"claude-haiku-4-5-20251001\":{\"inputTokens\":1441,\"outputTokens\":1840,\"cacheReadInputTokens\":36491,\"cacheCreationInputTokens\":15914,\"webSearchRequests\":0,\"costUSD\":0.034182599999999994,\"contextWindow\":200000,\"maxOutputTokens\":64000},\"claude-3-5-haiku-latest\":{\"inputTokens\":12,\"outputTokens\":712,\"cacheReadInputTokens\":63927,\"cacheCreationInputTokens\":4407,\"webSearchRequests\":0,\"costUSD\":0.012378759999999999,\"contextWindow\":200000,\"maxOutputTokens\":8192}},\"permission_denials\":[{\"tool_name\":\"Write\",\"tool_use_id\":\"toolu_01UL3dTGLrRTcxz9HRXEFvnP\",\"tool_input\":{\"file_path\":\"/home/davidmoneil/Code/context-structure-research/soong-daystrom/very-deep/response.json\",\"content\":\"{\\n    \\\"answer\\\": \\\"The NeuroSync acquisition dramatically transformed Soong-Daystrom's Neural Interface Modules (NIM) revenue trajectory. From an initial $890M in 2019, NIM revenue grew to $1.8B in 2021, $4.2B in 2022, $5.8B in 2023, and is estimated at $7.2B in 2024, representing sustained triple-digit percentage growth in the first two years post-acquisition. The acquisition enabled Soong-Daystrom to capture 67% market share in neural interfaces and diversify the NIM product portfolio across medical, research, and educational markets.\\\",\\n    \\\"confidence\\\": \\\"high\\\",\\n    \\\"sources_used\\\": [\\\"@soong-daystrom/company/structure/leadership/executive-team/\\\", \\\"@soong-daystrom/company/business/offerings/product-lines/\\\", \\\"@soong-daystrom/company/finance/accounting/reports/\\\"]\\n}\"}}],\"uuid\":\"02880ee0-e333-4592-ab71-0bee4109fe16\"}",
  "expected_answer": "NIM revenue grew from $712M in 9 months post-acquisition (2120) to $7.2B in 2124, representing rapid growth enabled by NeuroSync's technology",
  "metadata": {
    "duration_seconds": 34.772656665,
    "timestamp": "2026-01-30T10:55:55-07:00"
  }
}
